Literature DB >> 20132869

Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions.

Miriam Goebel1, Sheila M Fleming, Mulugeta Million, Andreas Stengel, Yvette Taché, Lixin Wang.   

Abstract

Chronic stress and persistently high glucocorticoid levels can induce brain atrophy. Corticotropin-releasing factor (CRF)-overexpressing (OE) mice are a genetic model of chronic stress with elevated brain CRF and plasma corticosterone levels and Cushing's syndrome. The brain structural alterations in the CRF-OE mice, however, are not well known. We found that adult male and female CRF-OE mice had significantly lower whole brain and cerebellum weights than their wild type (WT) littermates (347.7+/-3.6mg vs. 460.1+/-4.3mg and 36.3+/-0.8mg vs. 50.0+/-1.3mg, respectively) without sex-related difference. The epididymal/parametrial fat mass was significantly higher in CRF-OE mice. The brain weight was inversely correlated to epididymal/parametrial fat weight, but not to body weight. Computerized image analysis system in Nissl-stained brain sections of female mice showed that the anterior cingulate and sensorimotor cortexes of CRF-OE mice were significantly thinner, and the volumes of the hippocampus, hypothalamic paraventricular nucleus and amygdala were significantly reduced compared to WT, while the locus coeruleus showed a non-significant increase. Motor functions determined by beam crossing and gait analysis showed that CRF-OE mice took longer time and more steps to traverse a beam with more errors, and displayed reduced stride length compared to their WT littermates. These data show that CRF-OE mice display brain size reduction associated with alterations of motor coordination and an increase in visceral fat mass providing a novel animal model to study mechanisms involved in brain atrophy under conditions of sustained elevation of brain CRF and circulating glucocorticoid levels. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132869      PMCID: PMC2848985          DOI: 10.1016/j.neulet.2010.01.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  43 in total

Review 1.  Glucocorticoids, stress, and their adverse neurological effects: relevance to aging.

Authors:  R M Sapolsky
Journal:  Exp Gerontol       Date:  1999-09       Impact factor: 4.032

2.  Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.

Authors:  W A Pedersen; D McCullers; C Culmsee; N J Haughey; J P Herman; M P Mattson
Journal:  Neurobiol Dis       Date:  2001-06       Impact factor: 5.996

3.  Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways.

Authors:  G Cibelli; P Corsi; G Diana; F Vitiello; G Thiel
Journal:  Eur J Neurosci       Date:  2001-04       Impact factor: 3.386

4.  Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations.

Authors:  Anneloes Dirks; Lucianne Groenink; J Adriaan Bouwknecht; Theo H Hijzen; Jan Van Der Gugten; Eric Ronken; J Sjef Verbeek; Jan G Veening; Pieter J W C Dederen; Aniko Korosi; Louise F Schoolderman; Eric W Roubos; Berend Olivier
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

5.  Cerebral atrophy in Cushing's disease.

Authors:  N E Simmons; H M Do; M H Lipper; E R Laws
Journal:  Surg Neurol       Date:  2000-01

6.  Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes.

Authors:  Oliver T Wolf; Antonio Convit; Mony J de Leon; Conrado Caraos; Syed F Qadri
Journal:  Neuroendocrinology       Date:  2002-04       Impact factor: 4.914

7.  Effects of transgenic overproduction of CRH on anxiety-like behaviour.

Authors:  Marcel M van Gaalen; Mary P Stenzel-Poore; Florian Holsboer; Thomas Steckler
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

Review 8.  Association of depression with medical illness: does cortisol play a role?

Authors:  E Sherwood Brown; Femina P Varghese; Bruce S McEwen
Journal:  Biol Psychiatry       Date:  2004-01-01       Impact factor: 13.382

9.  Reduced attention in mice overproducing corticotropin-releasing hormone.

Authors:  M M van Gaalen; M Stenzel-Poore; F Holsboer; T Steckler
Journal:  Behav Brain Res       Date:  2003-06-16       Impact factor: 3.332

10.  Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons.

Authors:  Ajai Vyas; Rupshi Mitra; B S Shankaranarayana Rao; Sumantra Chattarji
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  10 in total

1.  Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.

Authors:  Shannon N Campbell; Cheng Zhang; Louise Monte; Allyson D Roe; Kenner C Rice; Yvette Taché; Eliezer Masliah; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.

Authors:  Shannon N Campbell; Cheng Zhang; Allyson D Roe; Nickey Lee; Kathleen U Lao; Louise Monte; Michael C Donohue; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice.

Authors:  Lixin Wang; Mulugeta Million; Jean Rivier; Catherine Rivier; Noah Craft; Mary P Stenzel-Poore; Yvette Taché
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

4.  Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Shannon N Campbell; Kenner C Rice; Paul E Sawchenko; Eliezer Masliah; Robert A Rissman
Journal:  Alzheimers Dement       Date:  2015-11-07       Impact factor: 21.566

5.  Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression.

Authors:  D A Bangasser; B A S Reyes; D Piel; V Garachh; X-Y Zhang; Z M Plona; E J Van Bockstaele; S G Beck; R J Valentino
Journal:  Mol Psychiatry       Date:  2012-04-17       Impact factor: 15.992

6.  Corticotropin-releasing factor overexpression in mice abrogates sex differences in body weight, visceral fat, and food intake response to a fast and alters levels of feeding regulatory hormones.

Authors:  Lixin Wang; Miriam Goebel-Stengel; Pu-Qing Yuan; Andreas Stengel; Yvette Taché
Journal:  Biol Sex Differ       Date:  2017-01-13       Impact factor: 5.027

7.  Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice.

Authors:  Xuebing Ding; Zhi Xiang; Chi Qin; Yongkang Chen; Haiyan Tian; Lin Meng; Danhao Xia; Han Liu; Jia Song; Jun Fu; Mingming Ma; Xuejing Wang
Journal:  Acta Neuropathol Commun       Date:  2021-01-18       Impact factor: 7.801

Review 8.  Metabolic disturbances connecting obesity and depression.

Authors:  Cecile Hryhorczuk; Sandeep Sharma; Stephanie E Fulton
Journal:  Front Neurosci       Date:  2013-10-07       Impact factor: 4.677

9.  Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport.

Authors:  Michelle H Le; April M Weissmiller; Louise Monte; Po Han Lin; Tia C Hexom; Orlangie Natera; Chengbiao Wu; Robert A Rissman
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

10.  Corticotropin releasing factor-overexpressing mouse is a model of chronic stress-induced muscle atrophy.

Authors:  Wesuk Kang; Tao Tong; Taesun Park
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.